- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Follicle Stimulating Hormone market will register a 4.4% CAGR in terms of revenue, the global market size will reach $ 1575.2 million by 2025, from $ 1328.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Follicle Stimulating Hormone business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Follicle Stimulating Hormone market by type, application, key manufacturers and key regions and countries.
This study considers the Follicle Stimulating Hormone value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Recombinant FSH
Urinary FSH
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Infertility Treatment
Assisted Reproductive Technology
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck Serono
MSD
Ferring
Livzon
IBSA
Gedeon Richter
Techwell
Teva
GenSci
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Follicle Stimulating Hormone consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Follicle Stimulating Hormone market by identifying its various subsegments.
Focuses on the key global Follicle Stimulating Hormone manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Follicle Stimulating Hormone with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Follicle Stimulating Hormone submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Follicle Stimulating Hormone Consumption 2015-2025
2.1.2 Follicle Stimulating Hormone Consumption CAGR by Region
2.2 Follicle Stimulating Hormone Segment by Type
2.2.1 Recombinant FSH
2.2.2 Urinary FSH
2.3 Follicle Stimulating Hormone Consumption by Type
2.3.1 Global Follicle Stimulating Hormone Consumption Market Share by Type (2015-2020)
2.3.2 Global Follicle Stimulating Hormone Revenue and Market Share by Type (2015-2020)
2.3.3 Global Follicle Stimulating Hormone Sale Price by Type (2015-2020)
2.4 Follicle Stimulating Hormone Segment by Application
2.4.1 Infertility Treatment
2.4.2 Assisted Reproductive Technology
2.5 Follicle Stimulating Hormone Consumption by Application
2.5.1 Global Follicle Stimulating Hormone Consumption Market Share by Type (2015-2020)
2.5.2 Global Follicle Stimulating Hormone Value and Market Share by Type (2015-2020)
2.5.3 Global Follicle Stimulating Hormone Sale Price by Type (2015-2020)
3 Global Follicle Stimulating Hormone by Company
3.1 Global Follicle Stimulating Hormone Sales Market Share by Company
3.1.1 Global Follicle Stimulating Hormone Sales by Company (2018-2020)
3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Company (2018-2020)
3.2 Global Follicle Stimulating Hormone Revenue Market Share by Company
3.2.1 Global Follicle Stimulating Hormone Revenue by Company (2018-2020)
3.2.2 Global Follicle Stimulating Hormone Revenue Market Share by Company (2018-2020)
3.3 Global Follicle Stimulating Hormone Sale Price by Company
3.4 Global Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Follicle Stimulating Hormone Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Follicle Stimulating Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Follicle Stimulating Hormone by Regions
4.1 Follicle Stimulating Hormone by Regions
4.2 Americas Follicle Stimulating Hormone Consumption Growth
4.3 APAC Follicle Stimulating Hormone Consumption Growth
4.4 Europe Follicle Stimulating Hormone Consumption Growth
4.5 Middle East & Africa Follicle Stimulating Hormone Consumption Growth
5 Americas
5.1 Americas Follicle Stimulating Hormone Consumption by Countries
5.1.1 Americas Follicle Stimulating Hormone Consumption by Countries (2015-2020)
5.1.2 Americas Follicle Stimulating Hormone Value by Countries (2015-2020)
5.2 Americas Follicle Stimulating Hormone Consumption by Type
5.3 Americas Follicle Stimulating Hormone Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Follicle Stimulating Hormone Consumption by Regions
6.1.1 APAC Follicle Stimulating Hormone Consumption by Regions (2015-2020)
6.1.2 APAC Follicle Stimulating Hormone Value by Regions (2015-2020)
6.2 APAC Follicle Stimulating Hormone Consumption by Type
6.3 APAC Follicle Stimulating Hormone Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Follicle Stimulating Hormone by Countries
7.1.1 Europe Follicle Stimulating Hormone Consumption by Countries (2015-2020)
7.1.2 Europe Follicle Stimulating Hormone Value by Countries (2015-2020)
7.2 Europe Follicle Stimulating Hormone Consumption by Type
7.3 Europe Follicle Stimulating Hormone Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Follicle Stimulating Hormone by Countries
8.1.1 Middle East & Africa Follicle Stimulating Hormone Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Follicle Stimulating Hormone Value by Countries (2015-2020)
8.2 Middle East & Africa Follicle Stimulating Hormone Consumption by Type
8.3 Middle East & Africa Follicle Stimulating Hormone Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Follicle Stimulating Hormone Distributors
10.3 Follicle Stimulating Hormone Customer
11 Global Follicle Stimulating Hormone Market Forecast
11.1 Global Follicle Stimulating Hormone Consumption Forecast (2021-2025)
11.2 Global Follicle Stimulating Hormone Forecast by Regions
11.2.1 Global Follicle Stimulating Hormone Forecast by Regions (2021-2025)
11.2.2 Global Follicle Stimulating Hormone Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Follicle Stimulating Hormone Forecast by Type
11.8 Global Follicle Stimulating Hormone Forecast by Application
12 Key Players Analysis
12.1 Merck Serono
12.1.1 Company Information
12.1.2 Follicle Stimulating Hormone Product Offered
12.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merck Serono Latest Developments
12.2 MSD
12.2.1 Company Information
12.2.2 Follicle Stimulating Hormone Product Offered
12.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 MSD Latest Developments
12.3 Ferring
12.3.1 Company Information
12.3.2 Follicle Stimulating Hormone Product Offered
12.3.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Ferring Latest Developments
12.4 Livzon
12.4.1 Company Information
12.4.2 Follicle Stimulating Hormone Product Offered
12.4.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Livzon Latest Developments
12.5 IBSA
12.5.1 Company Information
12.5.2 Follicle Stimulating Hormone Product Offered
12.5.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 IBSA Latest Developments
12.6 Gedeon Richter
12.6.1 Company Information
12.6.2 Follicle Stimulating Hormone Product Offered
12.6.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Gedeon Richter Latest Developments
12.7 Techwell
12.7.1 Company Information
12.7.2 Follicle Stimulating Hormone Product Offered
12.7.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Techwell Latest Developments
12.8 Teva
12.8.1 Company Information
12.8.2 Follicle Stimulating Hormone Product Offered
12.8.3 Teva Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Teva Latest Developments
12.9 GenSci
12.9.1 Company Information
12.9.2 Follicle Stimulating Hormone Product Offered
12.9.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 GenSci Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Follicle Stimulating Hormone Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
